Rotllan, N, Zhang, XB, Canfran-Duque, A, Goedeke, L, Grinan, R, Ramirez, CM, Suarez, Y, Fernandez-Hernando, C. Antagonism of miR-148a attenuates atherosclerosis progression in APOB(TG )Apobec(-/-)Ldlr(+/-) mice: A brief report. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 153DOI:10.1016/j.biopha.2022.113419. PMID:36076541. IF:7.500(Q1/1D).

Melé-Ninot G, Serra-Baldrich E, Spertino J, Guilarte M, Ribó González P, Lleonart-Bellfill R, Figueras-Nart I, Bonfill-Ortí M, Depreux N, Sala-Cunill A, Bielsa-Marsol I, Baliu-Piqué C, Sanmartín-Novell V, Garcia-Navarro X, Expósito-Serrano V, Garnica-Velandia D, Diaz-Sarrió MC, Gómez-Armayones S, Gich Saladich I, Giménez-Arnau A. Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?. EUROPEAN JOURNAL OF DERMATOLOGY. 2022; 32(5)DOI:10.1684/ejd.2022.4334. PMID:36468733. IF:2.500(Q2/5D).

Morales-Quinteros, L, Mancebo, J, Del Sorbo, L. Hypercapnia and extracorporeal carbon dioxide removal (ECCO2R) in the acute respiratory distress syndrome. Signa Vitae. 2022; 18(5)DOI:10.22514/sv.2022.046. PMID:. IF:1.100(Q4/9D).

Territo, A, Gallioli, A, Diana, P, Boissier, R, Fontana, M, Gaya, JM, Sanguedolce, F, Calderon, J, Piana, A, Fontanet, S, Algaba, F, Palou, J, Breda, A. DNA Methylation Urine Biomarkers Test in the Diagnosis of Upper Tract Urothelial Carcinoma: Results from a Single-Center Prospective Clinical Trial. JOURNAL OF UROLOGY. 2022; 208(3)DOI:10.1097/JU.0000000000002748. PMID:35549312. IF:6.600(Q1/2D).

Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments: a key new biomarker for clinicians Part 1: Importance of neurofilaments in the management of neurodegenerative diseases. ANNALES DE BIOLOGIE CLINIQUE. 2022; 80(5)DOI:10.1684/abc.2022.1757. PMID:36453742. IF:0.500(Q4/10D).

Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments: a key new biomarker for clinicians Part 2: Neurofilaments, an asset beyond neurodegenerative diseases. ANNALES DE BIOLOGIE CLINIQUE. 2022; 80(5)DOI:10.1684/abc.2022.1758. PMID:36453743. IF:0.500(Q4/10D).

Merchan-Galvis, A, Posso, M, Canovas, E, Jordan, M, Aguilera, X, Martinez-Zapata, MJ. Quality of life and cost-effectiveness analysis of topical tranexamic acid and fibrin glue in femur fracture surgery. BMC MUSCULOSKELETAL DISORDERS. 2022; 23(1)DOI:10.1186/s12891-022-05775-y. PMID:36045358. IF:2.300(Q2/5D).

Paneque, M, Juhe, CS, Melegh, B, Carreira, I, Moog, U, Liehr, T. On the necessity of recognizing so-called Core professional groups within the genetic healthcare in Europe (vol 34, pg 81, 2022). Medizinische Genetik. 2022; 34(2)DOI:10.1515/medgen-2022-2122. PMID:. IF:1.100(Q4/10D).

Hernandez, A, Munoz-Marmol, AM, Esteve-Codina, A, Alameda, F, Carrato, C, Pineda, E, Arpi-Llucia, O, Martinez-Garcia, M, Mallo, M, Gut, M, del Barco, S, Gallego, O, Dabad, M, Mesia, C, Bellosillo, B, Domenech, M, Vidal, N, Aldecoa, I, de la Iglesia, N, Balana, C. In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-18608-8. PMID:36002559. IF:4.600(Q2/4D).

Caravaca-Fontan, F, Rivero, M, Cavero, T, Diaz-Encarnacion, M, Cabello, V, Ariceta, G, Quintana, LF, Marco, H, Barros, X, Ramos, N, Rodriguez-Mendiola, N, Cruz, S, Fernandez-Juarez, G, Rodriguez, A, de Jose, AP, Rabasco, C, Rodado, R, Fernandez, L, Perez-Gomez, V, Avila, A, Bravo, L, Espinosa, N, Allende, N, de la Nieta, MDS, Rodriguez, E, Olea, T, Melgosa, M, Huerta, A, Miquel, R, Mon, C, Fraga, G, de Lorenzo, A, Draibe, J, Gonzalez, F, Shabaka, A, Lopez-Rubio, ME, Fenollosa, MA, Martin-Penagos, L, Da Silva, I, Titos, JA, de Cordoba, SR, de Jorge, EG, Praga, M. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy. Clinical Kidney Journal. 2022; 15(9)DOI:10.1093/ckj/sfac108. PMID:36003665. IF:4.600(Q1/2D).

Jorda, P, Bosman, LP, Gasperetti, A, Mazzanti, A, Gourraud, JB, Davies, B, Frederiksen, TC, Weidmann, ZM, Di Marco, A, Roberts, JD, MacIntyre, C, Seifer, C, Deliniere, A, Alqarawi, W, Kukavica, D, Minois, D, Trancuccio, A, Arnaud, M, Targetti, M, Martino, A, Oliviero, G, Pipilas, DC, Carbucicchio, C, Compagnucci, P, Dello Russo, A, Olivotto, I, Calo, L, Lubitz, SA, Cutler, MJ, Chevalier, P, Arbelo, E, Priori, SG, Healey, JS, Calkins, H, Casella, M, Jensen, HK, Tondo, C, Tadros, R, James, CA, Krahn, AD, Cadrin-Tourigny, J. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator. EUROPEAN HEART JOURNAL. 2022; 43(32)DOI:10.1093/eurheartj/ehac289. PMID:35766180. IF:39.300(Q1/1D).

Zozaya, N, Abdalla, F, Zamora, SA, Filgueiras, JB, Carrillo, JMC, Sanchez, OD, Sinisterra, FD, Garcia-Ruiz, A, Pinto, PH, Manfredi, A, Olmos, JM, Luna, PMD, Puig, L, Ros, S, HIdalgo-Vega, A. Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis. Expert Review of Pharmacoeconomics & Outcomes Research. 2022; 22(6)DOI:10.1080/14737167.2022.2063842. PMID:35404728. IF:2.300(Q3/7D).

del Alcazar, E, Lopez-Ferrer, A, Martinez-Domenech, A, Julia, M, Ruiz-Villaverde, R, Fernandez-Freire, LR, Notario, J, Llamas-Velasco, M, Ferran, M, Carrascosa, JM. Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group. JOURNAL OF DERMATOLOGICAL TREATMENT. 2022; 33(6)DOI:10.1080/09546634.2022.2079596. PMID:35593480. IF:2.900(Q2/4D).

Tonyali, S, Emiliani, E, Sener, TE, Pietropaolo, A, Ozsoy, M, Aboumarzouk, O, Somani, B, Kallidonis, P, Coninck, VMJD, Talso, M, Keller, EX, Macchione, N, Tailly, T. Definition of clinically insignificant residual fragments after percutaneous nephrolithotomy among urologists: a world-wide survey by EAU-YAU Endourology and Urolithiasis Working Group. Central European Journal Of Urology. 2022; 75(3)DOI:10.5173/ceju.2022.0115. PMID:36381161. IF:(Q/D).

Webb, SM, Valassi, E. Consequences of Cushing's Syndrome: Health Versus Personal Costs. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(9)DOI:10.1210/clinem/dgac269. PMID:35511590. IF:5.800(Q1/3D).

Silva, AMS, Rodrigo, P, Moreno, CAM, Mendonca, RD, Estephan, ED, Camelo, CG, Campos, ED, Dias, AT, Nascimento, AM, Kulikowski, LD, Oliveira, ASB, Reed, UC, Goldfarb, LG, Olive, M, Zanoteli, E. The Location of Disease-Causing DES Variants Determines the Severity of Phenotype and the Morphology of Sarcoplasmic Aggregates. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2022; 81(9)DOI:10.1093/jnen/nlac063. PMID:35898174. IF:3.200(Q2/5D).

Barrot, J, Real, J, Vlacho, B, Romero-Aroca, P, Simo, R, Mauricio, D, Mata-Cases, M, Castelblanco, E, Mundet-Tuduri, X, Franch-Nadal, J. Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.945245. PMID:36052329. IF:3.900(Q2/4D).

Esteve-Pastor, MA, Rivera-Caravaca, JM, Ruiz-Ortiz, M, Muniz, J, Roldan-Rabadan, I, Otero, D, Lopez-Galvez, R, Cequier, A, Bertomeu-Martinez, V, Badimon, L, Anguita, M, Lip, GYH, Marin, F. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry. EXPERT OPINION ON PHARMACOTHERAPY. 2022; 23(12)DOI:10.1080/14656566.2022.2109961. PMID:35924672. IF:3.200(Q3/6D).

Cobo J., Coronas R., Pousa E., Oliva J.-C., Giménez-Palop O., Caixàs A.. An adapted scale to evaluate insight in Prader-Willi Syndrome. MEDICINA CLINICA. 2022; 159(3)DOI:10.1016/j.medcli.2021.07.015. PMID:34696903. IF:3.900(Q2/4D).

Nunez-Gil, IJ, Vedia, O, Almendro-Delia, M, Raposeiras-Roubin, S, Sionis, A, Martin-Garcia, A, Martin-Garcia, A, Andres, M, Blanco, E, Martin-de-Miguel, I, Uribarri, A, Corbi-Pascual, M, Feltes, G, Bosch, X, Fabregat-Andres, O, Lopez-Pais, J, Sanchez-Grande-Flecha, A, Guillen-Marzo, M. Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO (vol 155, pg 521, 2020). MEDICINA CLINICA. 2022; 159(3)DOI:10.1016/j.medcli.2022.03.001. PMID:35570030. IF:3.900(Q2/4D).